Contacts |
| Request of offer |
| Contact Us |
| For any suggestion and comment |
Courses and seminar |
13/11/2008TÜV Rheinland Italia and Spinlab invite you to the “Technical and Informative Seminar about safety standards for bycicles and components” – Pove del Grappa (VI) – 28th November 2008 |
06/11/2008TÜV Rheinland Italia organizes the training course "Safety in playgrounds: building, installation, maintenance and inspection of the areas" - Ponte San Marco (BS) – 2/3/4 December 2008 |
| show all courses |
News |
15/10/200815th & 16th October 2008 - Cologne 3rd International Rail Symposium |
23/09/2008VALVITALIA opens the new industrial park in the surroundings of Pavia – 29th September 2008, 4 p.m. |
| show all news |
| Industry Solutions | Products + Services | ID-Certificate | |||
| Home |
Scope of Directive
The In Vitro Diagnostic Medical Directive (IVDD) 98/79/EC published in October 1998 will become mandatory in December 2003 for all in vitro diagnostic medical devices not covered by the MDD or the AIMDD.
This directive divides in vitro diagnostic medical devices into 5 product groups, depending on their intended use and the risks involved:
1. Devices for self-testing by lay persons in a home environment.
2. In Annex II List A-reagents and reagent products, including calibrators and control materials for determining particular blood groups (ABO, Rhesus, anti-Kell) and for the detection of HIV, HTLV or Hepatitis B, C and D.
3. In Annex II List B-reagents and reagent products, including calibrators and control materials:
· For determining the blood groups anti-Duffy and anti-Kidd,
· For determining irregular anti-erythrocytic antibodies
· For diagnosing the hereditary disease phenylketonuria
· For detecting rubella or toxoplasmosis
· For determining cytomegalovirus and chlamydia
· For determining the HLA tissue groups; DR, A, B
· For determining the tumoral marker PSA
· For evaluating the risk of trisomy 21
· Products for self-diagnosis: device for measurement of blood sugar.
4. Devices for purposes of performance evaluation, which are intended to be subjected to performance evaluation studies outside the manufacturer's own premises.
5. Other in-vitro diagnostic medical devices: Devices not listed in Annex II and which are not intended for self-testing or for purposes of performance evaluation.

The "Essential Requirements" of the IVDD shall be supported by test reports based on harmonized standards (ENs). The use of harmonized standards presumes compliance with the Essential Requirements (Annex I). The tests can be completed by a first, second or third-party organization, which would be affiliated with a Notified Body.
European directive 98/79/EC on in vitro diagnostics |